Lotus Eye Hospital and Institute vs HCA Healthcare: Fair Value & Quality
Both stocks run through our valuation models. Here is how Lotus Eye Hospital and Institute (LOTUSEYE) and HCA Healthcare (HCA) compare, as of Aug 18, 2026.
As of Aug 18, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: Lotus Eye Hospital and Institute trades at ₹116 versus a fair value of ₹81.06 (-30%), while HCA Healthcare trades at $405 versus $548 (+35%).
Lotus Eye Hospital and Institute
LOTUSEYE.NSE · INR · Health Care
-30%
upside to fair value
overvalued
Price₹116
Fair Value₹81.06
Quality47/100
HCA Healthcare
HCA · USD · Health Care
+35%
upside to fair value
undervalued
Price$405
Fair Value$548
Quality70/100
Get comparisons like this free by email every month: the most undervalued quality stocks.
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Lotus Eye Hospital and InstituteHCA Healthcare
Valuation
—P/E (TTM)14.0×
0.05×P/S (TTM)1.06×
0.05×P/B—
2.7×EV/EBITDA7.8×
—PEG1.18×
—Dividend yield0.8%
—Dividend per share$2.94
Profitability
0%Net margin9%
-5%Operating margin15%
0%Return on equity136%
-0%Return on assets12%
Growth
18%Revenue growth (YoY)4%
4.5%Avg. growth/yr (3Y)7.9%
10.7%Avg. growth/yr (5Y)8.0%
Balance & size
0.17×Debt / equity—
$27MMarket cap$81B
expensiveGrowth qualityhealthy
HCA Healthcare leads: 4 to 5 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
Lotus Eye Hospital and Instituteof which business quality 50 · market factors 63HCA Healthcareof which business quality 66 · market factors 38
ProfitabilityMargins and returns on capital today
23
76
Quality GrowthAre margins and returns improving?
32
61
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
49
75
Low VolatilityCalm price path (market factor)
61
59
MomentumPrice trend over the last 3–12 months (market factor)
61
26
52W MomentumDistance to the 52-week high (market factor)
69
36
Net IssuanceBuybacks instead of dilution
97
100
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
Lotus Eye Hospital and Institute
Earnings-Based₹24.79
Dividend Discount₹8.58
Multiples₹72.00
Asset-Based₹1,847
Economic Profit₹1,617
Growth Earnings₹72.48
9 of 12 models see the stock below the current price.
HCA Healthcare
DCF Models$546
Earnings-Based$289
Dividend Discount$53.85
Multiples$673
Growth DCF$540
Economic Profit$419
Growth Earnings$506
6 of 23 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Lotus Eye Hospital and Institute
Bear ₹61.03Fair Value ₹81.06Bull ₹101
₹116 = current price (white tick)
HCA Healthcare
Bear $260Fair Value $548Bull $841
$405 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Lotus Eye Hospital and Institute · Health Care
Quality score47 · below median
Fair value upside-30% · below median
HCA Healthcare · Health Care
Quality score70 · Top 25%
Fair value upside+35% · Top 25%
Bottom line
As of Aug 18, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: Lotus Eye Hospital and Institute trades at ₹116 versus a fair value of ₹81.06 (-30%), while HCA Healthcare trades at $405 versus $548 (+35%).
HCA Healthcare has the higher quality score (70/100).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
